Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
+$351M |
| 2 |
Netflix
NFLX
|
+$343M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$293M |
| 4 |
Nike
NKE
|
+$186M |
| 5 |
Delta Air Lines
DAL
|
+$177M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$1.33B |
| 2 |
Tesla
TSLA
|
+$344M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$306M |
| 4 |
NVIDIA
NVDA
|
+$281M |
| 5 |
Boeing
BA
|
+$251M |
Sector Composition
| 1 | Technology | 19.27% |
| 2 | Healthcare | 18.45% |
| 3 | Consumer Discretionary | 12.35% |
| 4 | Consumer Staples | 10.15% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Valaris
VAL
$3.73B
| $907K | ﹤0.01% |
+12,100
| New | +$907K |
|
2377
Avantis US Equity ETF
AVUS
$9.65B
| $901K | ﹤0.01% |
12,300
-14,600
| -54% | -$1.07M |
|
|
ARGO
2378
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $897K | ﹤0.01% |
+30,058
| New | +$897K |
|
2379
Xencor
XNCR
$660M
| $893K | ﹤0.01% |
44,300
-83,973
| -65% | -$1.69M |
|
|
FREE
2380
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $892K | ﹤0.01% |
247,700
+32,200
| +15% | +$116K |
|
2381
Vanguard S&P 500 Growth ETF
VOOG
$20.1B
| $889K | ﹤0.01% |
3,600
-4,000
| -53% | -$988K |
|
|
ORTX
2382
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $888K | ﹤0.01% |
114,818
-10,400
| -8% | -$80.4K |
|
2383
First US Bancshares
FUSB
$70.4M
| $887K | ﹤0.01% |
103,721
-2,100
| -2% | -$18K |
|
2384
Installed Building Products
IBP
$7.15B
| $887K | ﹤0.01% |
+7,100
| New | +$887K |
|
2385
Kforce
KFRC
$571M
| $886K | ﹤0.01% |
14,849
-200
| -1% | -$11.9K |
|
|
TRTX
2386
TPG RE Finance Trust
TRTX
$727M
| $882K | ﹤0.01% |
131,094
-93,100
| -42% | -$626K |
|
2387
HUTCHMED
HCM
$3B
| $881K | ﹤0.01% |
52,000
-3,452
| -6% | -$58.5K |
|
2388
Luxfer Holdings
LXFR
$369M
| $881K | ﹤0.01% |
67,500
-45,900
| -40% | -$599K |
|
2389
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
$1.75B
| $880K | ﹤0.01% |
+12,100
| New | +$880K |
|
|
FGH
2390
DELISTED
FG Group Holdings Inc.
FGH
| $880K | ﹤0.01% |
523,830
-22,600
| -4% | -$38K |
|
2391
First Trust NYSE Arca Biotechnology Index Fund
FBT
$1.08B
| $878K | ﹤0.01% |
6,000
+3,000
| +100% | +$439K |
|
2392
loanDepot
LDI
$955M
| $877K | ﹤0.01% |
510,100
-49,879
| -9% | -$85.8K |
|
2393
NetSol Technologies
NTWK
$60.5M
| $872K | ﹤0.01% |
481,801
-16,600
| -3% | -$30K |
|
2394
Enviri
NVRI
$1.01B
| $871K | ﹤0.01% |
120,696
+81,962
| +212% | +$591K |
|
2395
Life Time Group Holdings
LTH
$6.17B
| $870K | ﹤0.01% |
+57,200
| New | +$870K |
|
2396
Good Times Restaurants
GTIM
$17.3M
| $868K | ﹤0.01% |
291,283
-17,585
| -6% | -$52.4K |
|
2397
Sabre
SABR
$726M
| $868K | ﹤0.01% |
+193,400
| New | +$868K |
|
2398
Colony Bankcorp
CBAN
$299M
| $867K | ﹤0.01% |
86,778
+1,900
| +2% | +$19K |
|
2399
WisdomTree US LargeCap Dividend Fund
DLN
$5.33B
| $867K | ﹤0.01% |
14,100
+5,100
| +57% | +$314K |
|
2400
Carisma Therapeutics
CARM
$13.1M
| $866K | ﹤0.01% |
204,695
+102,935
| +101% | +$435K |
|